Citations

Clear

7552 citation(s) found for "Ku, Matthew".

Antifouling Immunomodulatory Copolymer Architectures That Inhibit the Fibrosis of Implants
Jeang, William J. , Jiang, Alexis L., Bose, Suman , Collins, Evan , McMullen, Patrick , Rosenboom, Jan‐Georg , Lathwal, Sushil , Langer, Robert , Anderson, Daniel G , Wong, Bryan Matthew , Zhao, Yichao , Manan, Rajith S. , Langer, Róbert , Anderson, Daniel G.

Mayo Clinic

Advanced Materials | December 25, 2024 | Volume: 37 | Issue: 7 | Pages: No page available

10.1002/adma.202414743 | PMID 39722171 Get It

Abstract Immune reactions to medical implants often lead to encapsulation by fibrotic tissue and impaired device function. This process is thought to initiate by protein adsorption, which enables immune cells to attach and mount an inflammatory response. Previously, several antifibrotic materials have been either designed to reduce protein adsorption or discovered via high‐throughput screens (HTS) to favorably regulate inflammation. The present work introduces antifouling immunomodulatory (AIM) copolymer coatings, which combine both strategies to effectively enhance implant protection. AIM copolymers synergistically integrate zwitterionic moieties to resist protein fouling, HTS‐derived antifibrotics for immunomodulation, and silane monomers for grafting to diverse substrates including elastomers, ceramics, and metals. Interestingly, simply combining these monomers into conventional random or block copolymer architectures yielded no significant advantage over homopolymers. By contrast, an unusual polymer chain architecture — a zwitterionic block flanked by a mixed zwitterionic immunomodulatory segment — showed superior fibrosis resistance in both peritoneal and subcutaneous sites over one month in immunocompetent mice. This architecture also improved the performance of two different HTS‐derived antifibrotic monomers, suggesting that tailoring AIM architectures may broadly complement immunomodulatory chemistries and provide a versatile approach to improving implant longevity.
The Intraosseous Subarcuate Loop of Anterior Inferior Cerebellar Artery: Anatomic Management Guide, Single-Center MRI Study, and Scoping Review
Plou, Pedro , Athanasoulis, Filippos , Kollia, Sofia , Leonel, Luciano, Carlson, Matthew L. , Link, Michael J. , Peris‐Celda, Maria , De Bonis, Alessandro, Torregrossa, Fábio , Serioli, Simona , Leonel, Luciano César P C, Carlson, Matthew, Bonis, Alessandro De, Bauman, Megan M. J.

Mayo Clinic

Operative Neurosurgery | December 24, 2024 | Volume: 29 | Issue: 3 | Pages: 389-398

10.1227/ons.0000000000001474 | PMID 39716468 Get It

BACKGROUND AND OBJECTIVES: The intraosseous subarcuate loop (SL) is a unique variant of the anterior inferior cerebellar artery (AICA), where a loop of the artery is trapped in the petrous bone's subarcuate fossa (SF). Recognizing this variant is crucial for planning cerebellopontine angle (CPA) surgeries; however, data regarding its frequency and management vary in the published literature. A cohort from a single center was studied using MRI to assess its prevalence, and the findings were compared with the existing literature. In addition, an intraoperative guide for mobilizing the intraosseous AICA's SL was provided through a detailed step-by-step cadaveric dissection. METHODS: Two hundred fifty-eight patients who had undergone MRI scans of the CPA (516 sides) were retrospectively reviewed. MRIs displaying vascular loops visible in the axial view were analyzed using multiplanar reconstruction, and the intraosseous loop frequency was evaluated. A scoping review was undertaken to provide an overview of previously published data on its prevalence. One embalmed and latex-injected specimen with intraosseous AICA's SL was dissected through a retrosigmoid approach, and 1 surgical case was detailed, describing the procedure to release it. RESULTS: Intraosseous AICA's SL mobilization involves the identification of its entry and exit points within the petrous bone, dural incision to expose the SF, SF drilling, subarcuate artery division, and detaching the vascular loop. Preservation of a dural cuff is crucial to prevent vascular injury. We analyzed 258 brain MRIs (mean age 55 years, 42% male). The intraosseous AICA's SL was present in 4 of 516 evaluated CPAs (0.8%). The prevalence of the vascular anomaly in the reviewed literature using different radiological modalities ranged from 0.2% to 1.6%. CONCLUSION: The intraosseous AICA's SL is an uncommon anatomic variation detectable by MRI, posing an added risk in CPA surgery. Identifying and properly mobilizing it is crucial for safe vascular preservation.
A Multi‐Center Study of Ossiculoplasty Hearing Outcomes and a Grading Scale of Ear Environment Risk
Gluth, Michael B. , Judd, Ryan T. , Gurgel, Richard K. , Dornhoffer, John L., Kutz, Joe Walter , Carlson, Matthew L. , Kuthubutheen, Jafri , Anderson, Ryan D., Killeen, Daniel E. , Barnes, Jason H. , Fussell, Wanda L., Jeganathan, Chaithanya, Kutz, Walter , Gurgel, Richard Klaus , Anderson, Ryan D., Jeganathan, Chaithanya

Mayo Clinic

The Laryngoscope | December 23, 2024 | Volume: 135 | Issue: S2 | Pages: No page available

10.1002/lary.31965 | PMID 39714957 Get It

ObjectiveTo determine which ear environment risk factors impact ossiculoplasty hearing outcomes and to generate a statistically‐valid grading system for ossiculoplasty outcome reporting.Study TypeRetrospective case series.MethodsA multi‐institutional database was generated from cases performed between 2011 and 2019. Preoperative and postoperative hearing thresholds were recorded alongside potential ear environment risk factors. Multiple variable linear regression statistical analyses of risk factors were applied to determine independent association with postoperative pure tone average air‐bone gap (PTA‐ABG). Significant factors were used to generate a statistically‐weighted grading scale of Ear Environment Risk (EER).Results1679 cases had a mean follow‐up time of 33.6 months (SD 36.3) and a mean postoperative PTA‐ABG of 21.2 (SD 12.8). Multiple revision status (p < 0.001), presence of canal wall down mastoidectomy cavity (p = 0.020), absent malleus (p < 0.001), absent stapes superstructure (p = 0.016), frequent otorrhea (p = 0.008), pediatric age (p < 0.001), and blunted/lateralized tympanic membrane (p = 0.003) were independently correlated with PTA‐ABG. These factors were incorporated into an EER Scoring System with four distinct risk groups wherein each risk group was significantly correlated with PTA‐ABG, and this grading system was better correlated with PTA‐ABG (Kendall's τ = 0.193) than other existing published grading scales.ConclusionGrading environment risk according to a novel EER scoring system generates meaningful risk groupings that correlate with ossiculoplasty postoperative PTA‐ABG, and this holds potential to frame reporting of hearing outcomes for future ossiculoplasty research.Level of Evidence3 Laryngoscope, 135:S1–S11, 2025
Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA
Riviere-Cazaux, Cécile , Dong, Xiaoxi , Mo, Wei , Kumar, Rahul , Dai, Chao , Carlstrom, Lucas P. , Munoz-Casabella, Amanda , Nesvick, Cody L. , Andersen, Katherine M., Hoplin, Matthew D. , Canaday, Nicholas, Jusué-Torres, Ignacio , Malik, Noor , Campian, Jian L., Ruff, Michael W. , Uhm, Joon H. , Eckel‐Passow, Jeanette E. , Kizilbash, Sani H. , Warrington, Arthur E. , Jenkins, Robert B. , Du, Pan , Jia, Shidong , Ghadimi, Keyvan , Nesvick, Cody L , Andersen, Katherine M , Hoplin, Matthew D , Canaday, Nicholas , Jusue-Torres, Ignacio , Malik, Noor , Campian, Jian L , Ruff, Michael W , Uhm, Joon H , Eckel-Passow, Jeanette E , Kaufmann, Timothy J , Routman, David M , Kizilbash, Sani H , Sener, Ugur , Warrington, Arthur E , Jenkins, RB , Du, Pan , Jia, Shidong , Burns, Terry C , Kumar, Rahul , Kaufmann, Timothy J. , Routman, David M. , Sener, Uğur , Burns, Terry C.

Mayo Clinic

Clinical Cancer Research | December 23, 2024 | Volume: 31 | Issue: 5 | Pages: 881-889

10.1158/1078-0432.ccr-24-1814 | PMID 39715486 Get It

Abstract Purpose: Current methods for glioma response assessment are limited. This study aimed to assess the technical and clinical feasibility of molecular profiling using longitudinal intracranial cerebrospinal fluid (CSF) from patients with gliomas. Experimental Design: Adults with gliomas underwent longitudinal intracranial CSF collection via Ommaya reservoirs or ventriculoperitoneal shunts. Cell-free DNA (cfDNA) was extracted and analyzed using PredicineCARE for cancer variant profiling and/or PredicineSCORE for low-pass whole-genome sequencing. Results: Five patients (two females and three males; median age, 40 years; range, 32–64 years) underwent longitudinal intracranial CSF collection via Ommaya reservoirs (n = 4) or ventriculoperitoneal shunts (n = 1). In total, 47 CSF samples were obtained (median volume, 4.00 mL; 0.5–5 mL). Forty-one samples (87.2%) yielded sufficient cfDNA for testing. Patient-specific tumor-associated variant allelic frequencies (VAF), and thus tumor fraction, decreased in pre- versus postchemoradiation samples, including through pseudoprogression. These also increased with radiographic progression in three patients, although identifying the time of definitive disease progression from MRIs was a significant limitation. In two patients with isocitrate dehydrogenase (IDH)–mutant gliomas, decreasing IDH1 VAF after resection and chemoradiation correlated with decreased CSF D-2-hydroxyglutarate levels (0.64× and 0.62×, respectively, for the first patient and 0.01× and 0.07× for the other patient), although D-2-hydroxyglutarate and IDH1 VAF were not concordant in one patient thereafter. Moreover, the copy-number burden decreased below the limit of quantification during treatment and increased above the limit at progression. Conclusions: Longitudinal intracranial CSF cfDNA can be obtained in patients with gliomas during their disease course. However, before deploying this technique, numerous questions and challenges should be answered.
Outcomes Following Direct Anterior Approach Total Hip Arthroplasty
Wilson, Jacob M. , Hadley, Matthew L. , Ledford, Cameron K. , Bingham, Joshua S. , Wyles, Cody C. , Taunton, Michael J. , Wyles, Cody C , Taunton, Michael J , Bingham, Joshua S , Ledford, Cameron K , Larson, Dirk R.

Mayo Clinic

Journal of Bone and Joint Surgery | December 23, 2024 | Volume: 107 | Issue: 4 | Pages: 356-363

10.2106/jbjs.24.00132 | PMID 39715296 Get It

Background: The direct anterior approach (DAA) is a popular approach for primary total hip arthroplasty (THA). However, the contemporary outcomes for DAA THA need further elucidation. Therefore, we aimed to describe implant survivorship, complications, and clinical outcomes after DAA THA. Methods: From our multi-institutional total joint registry, 3,184 patients who had undergone 3,698 primary DAA THA between 2010 and 2019 were identified. The identified patients had a mean age of 65 years and a mean body mass index (BMI) of 29 kg/m 2 , and 53% of patients were female. The indications for revision and reoperation and the incidence of complications were collected and analyzed. Potential risk factors, including age, sex, BMI, and high-volume compared with low-volume operating surgeons, were examined. Descriptive statistics and Kaplan-Meier survivorship with Cox regression analyses were performed. Results: At 10 years following primary DAA THA, the cohort had 96% (95% confidence interval [CI], 95% to 98%) survivorship free of any revision and 94% (95% CI, 92% to 96%) survivorship free of any reoperation. The leading indications for revision were periprosthetic joint infection (PJI) (n = 24; 5-year cumulative incidence, 0.93% [95% CI, 0.6% to 1.5%]), periprosthetic fracture (n = 20; 5-year cumulative incidence, 0.62% [95% CI, 0.4% to 1.0%]), and aseptic loosening (n = 14; 11 femoral, 3 acetabular; 5-year cumulative incidence, 0.84% [95% CI, 0.5% to 1.5%]). A BMI of ≥40 kg/m 2 was found to be significantly associated with PJI (hazard ratio [HR], 6.4; p < 0.001), reoperation (HR, 3.5; p < 0.001), and nonoperative complications (HR, 2.3; p = 0.018). Survivorship free of recurrent instability was 99.6% (95% CI, 99.4% to 99.8%) at 5 and 10 years, and the cumulative incidence of revision for instability was 0.14% at 5 years. Conclusions: In one of the largest published series to date, survivorship following DAA THA was satisfactory at early to intermediate follow-up. The leading indications for revision were PJI, periprosthetic fracture, and aseptic loosening. Instability after DAA THA was uncommon and infrequently led to revision. As a note of caution, a BMI of ≥40 kg/m 2 was identified as a risk factor for adverse outcome after DAA THA. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity
Gruenbaum, Benjamin F. , Merchant, Kiran S. , Boyko, Matthew , Boyko, Matthew , Gruenbaum, Benjamin Fredrick , Merchant, Kiran S , Zlotnik, Alexander Anatolievich

Mayo Clinic

Nutrients | December 23, 2024 | Volume: 16 | Issue: 24 | Pages: 4405

10.3390/nu16244405 | PMID 39771027 Get It

The gut–brain axis plays an integral role in maintaining overall health, with growing evidence suggesting its impact on the development of various neuropsychiatric disorders, including depression. This review explores the complex relationship between gut microbiota and glutamate (Glu) regulation, highlighting its effect on brain health, particularly in the context of depression following certain neurological insults. We discuss how microbial populations can either facilitate or limit Glu uptake, influencing its bioavailability and predisposing to neuroinflammation and neurotoxicity. Additionally, we examine the role of gut metabolites and their influence on the blood–brain barrier and neurotransmitter systems involved in mood regulation. The therapeutic potential of microbiome-targeted interventions, such as fecal microbiota transplantation, is also highlighted. While much research has explored the role of Glu in major depressive disorders and other neurological diseases, the contribution of gut microbiota in post-neurological depression remains underexplored. Future research should focus on explaining the mechanisms linking the gut microbiota to neuropsychiatric outcomes, particularly in conditions such as post-stroke depression, post-traumatic brain-injury depression, and epilepsy-associated depression. Systematic reviews and human clinical studies are needed to establish causal relationships and assess the efficacy of microbiome-targeted therapies in improving the neuropsychiatric sequalae after neurological insults.
Premenopausal bilateral oophorectomy and Alzheimer's disease imaging biomarkers later in life
Kantarci, Kejal, Kapoor, Ekta , Geske, Jennifer R. , Fields, Julie A. , Knyazhanskaya, Evdokiya , Schwarz, Christopher G., Bailey, Kent R. , Lowe, Val J. , Rocca, Walter A. , Kantarci, Kejal , Castillo, Anna , Knyazhanskaya, Evdokiya E, Kantarci, Kejal , Geske, Jennifer , Kapoor, Ekta , Kara, Firat , Schwarz, Christopher G. , Senjem, Matthew L. , LeBrasseur, Nathan K. , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia | December 23, 2024 | Volume: 21 | Issue: 7 | Pages: No page available

10.1002/alz.14469 | PMID 39711285 Get It

Abstract INTRODUCTION Premenopausal bilateral oophorectomy (PBO) before the age of 46 years is associated with an increased risk of dementia. We investigated the long‐term effects of PBO performed before age 50 years on amyloid beta (Aβ), tau, and neurodegeneration imaging biomarkers of Alzheimer's disease (AD). METHODS Mayo Clinic Cohort Study of Oophorectomy and Aging‐2 participants were divided into early PBO (< 46 years; n = 61), and late PBO (46–49 years; n = 51) groups and were compared to referent women who did not undergo PBO ( n = 119). RESULTS Early PBO was associated with thinner entorhinal cortex ( p = 0.014), higher tau load at higher levels of Aβ load ( Pp = 0.005), higher Aβ load ( p = 0.026), and smaller temporal lobe cortical thickness ( p = 0.022), only at older ages compared to the referent group. DISCUSSION PBO before the age of 46 years is associated with entorhinal cortex thinning, elevated tau at higher Aβ levels, along with an AD‐like pattern of atrophy at older ages. CLINICAL TRIALS REGISTRATION NCT03821857 sex‐specific effects of endocrine disruption on aging and AD. Highlights Premenopausal bilateral oophorectomy (PBO) before the ages of 46 (early PBO) years and ages 46 to 49 (late PBO) years was studied. Early PBO was associated with reduced entorhinal cortex thickness later in life. Early PBO was associated with greater amyloid beta (Aβ) load at older ages. Early PBO was associated with greater Alzheimer's disease pattern of atrophy at older ages. Early PBO was associated with higher tau load at higher Aβ levels.
Patient-centric Summarization of Radiology Findings Using Two-step Training of Large Language Models
Tariq, Amara , Trivedi, Shubham , Khan, Aisha Urooj , Ramasamy, Gokul , Fathizadeh, Sam, Stib, Matthew T. , Tan, Nelly , Patel, Bhavik N. , Banerjee, Imon , Banerjee, Imon , Fathizadeh, Sam , Urooj, Aisha

Mayo Clinic

ACM Transactions on Computing for Healthcare | December 21, 2024 | Volume: 6 | Issue: 2 | Pages: 1-15

10.1145/3709154 Get It

Education-level or socioeconomic background of patients may dictate their ability to understand medical jargon. Inability to understand primary findings from a radiology report may lead to unnecessary anxiety among patients or missed follow up. We aim to meet this challenge by developing a patient-sensitive summarization model for radiology reports. We selected computed tomography (CT) exams of chest as a use-case and collected 7,000 studies from Mayo Clinic. Summarization model was built on top of the T5 large language model (LLM) as our experiments indicated that its text-to-text transfer architecture was suited for abstractive text summarization, resulting in a model with 0.77B trainable parameters. Noisy ground truth for model training was collected by prompting LLaMA-13B model. We recruited experts (board-certified radiologists) and laymen to manually evaluate model-generated summaries generated by model. Our model rarely missed information as marked by majority opinion of radiologists. Laymen indicated 63% improvement in their understanding by reading model-generated layman summaries. Comparison with zero-shot performance of ChatGPT indicated that the proposed model reduced the rate of hallucination by half and rate of missing important information by fivefold. The proposed model can generate reliable summaries for radiology reports understandable by patients with vastly different levels of medical knowledge.
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies
Davids, Matthew S. , Brander, Danielle M. , Alvarado, Yesid , Egan, Daniel Nathan, Dinner, Shira, Malki, Monzr M. Al , Begna, Kebede H. , Bhatt, Vijaya Raj , Abedin, Sameem , Cook, Rachel J. , Collins, Mary C. , Roleder, Carly , Rajagopalan, Prabhu , Danilov, Alexey V., Alvarado-Valero, Yesid , Diefenbach, Catherine S , Egan, Daniel N , Dinner, Shira N , Javidi-Sharifi, Nathalie , Al Malki, Monzr M , Begna, Kebede , Bhatt, Vijaya Raj , Abedin, Sameem , Cook, Rachel J , Collins, Mary C , Roleder, Carly , Dominguez, Edward C , Rajagopalan, Prabhu , Wiley, Sandra E , Ghalie, Richard G , Danilov, Alexey V , Davids, Matthew S , Diefenbach, Catherine , Egan, Daniel

Mayo Clinic

Blood Advances | December 20, 2024 | Volume: 9 | Issue: 4 | Pages: 820-832

10.1182/bloodadvances.2024014633 | PMID 39705540 Get It

Abstract The antiapoptotic protein, myeloid cell leukemia-1 (Mcl-1), contributes to the pathophysiology of acute myeloid leukemia (AML) and certain B-cell malignancies. Tumor dependence on Mcl-1 is associated with resistance to venetoclax. Voruciclib, an oral cyclin-dependent kinase (CDK) inhibitor targeting CDK9, indirectly decreases Mcl-1 protein expression and synergizes with venetoclax in preclinical models. This dose escalation study evaluated voruciclib in patients with previously treated hematologic malignancies. Initially, voruciclib was administered daily, continuously, on a 28-day cycle (group 1). After 2 patients with prior allogeneic stem cell transplantation had a dose-limiting toxicity (DLT) of interstitial pneumonitis at 100 mg, voruciclib administration was changed to days 1 to 14 of a 28-day cycle (group 2). Forty patients, 21 with AML and 19 with B-cell malignancies, were enrolled. Patients had a median of 3 prior lines of therapy (range, 1-8). Dose escalation in group 2 was stopped at 200 mg, a dose that achieved plasma concentrations sufficient for target inhibition, without DLTs observed. The most common adverse events were diarrhea (30%), nausea (25%), anemia (22%), fatigue (22%), constipation (17%), dizziness (15%), and dyspnea (15%). In AML, 1 patient achieved a morphologic leukemia-free state, and 2 had stable disease. Voruciclib treatment led to a decrease in MCL1 messenger RNA expression, downregulation of myelocytomatosis (MYC) and NF-κB transcriptional gene sets, and reduced phosphorylation of RNA polymerase 2. Voruciclib on intermittent dosing was well tolerated, with no DLTs, paving the way for evaluation of the combination of voruciclib with venetoclax for patients with previously treated AML. This trial was registered at www.clinicaltrials.gov as #NCT03547115.
Prospective Noninvasive Hemoglobin Monitoring in the Outpatient Total Joint Arthroplasty Setting
Dugdale, Evan M. , Mallinger, Benjamin D, Bedard, Nicholas A. , Couch, Cory , Mabry, Tad M. , Perry, Kevin I. , Sierra, Rafael J. , Taunton, Michael J. , Trousdale, Robert T. , Abdel, Matthew P. , Couch, Cory C , Abdel, Matthew P , Sierra, Rafael J , Taunton, Michael J , Bedard, Nicholas A , Mallinger, Benjamin D , Perry, Kevin I.

Mayo Clinic

Journal of Bone and Joint Surgery | December 20, 2024 | Volume: 107 | Issue: 4 | Pages: 364-371

10.2106/jbjs.24.00438 | PMID 39705371 Get It

Background: Total joint arthroplasty (TJA) is increasingly being performed as an outpatient (i.e., same-day discharge) procedure. Postoperatively, orthostatic hypotension or pain-related tachycardia can lead to concerns regarding the hemoglobin (Hgb) level of the patient prior to discharge. The purpose of this study was to prospectively assess the reliability and accuracy of, and patient and nurse satisfaction with, postoperative noninvasive hemoglobin (nHgb) monitoring compared with an invasive serum hemoglobin (iHgb) laboratory draw in the outpatient TJA setting. Methods: We prospectively enrolled 200 patients undergoing outpatient unilateral TJA, of whom 157 were ultimately included in our analysis (94 hips, 63 knees). Postoperatively, both nHgb and iHgb values were obtained at a mean of 36 minutes apart. Surveys were completed by patients and nurses. The strength of the agreement between the 2 Hgb monitoring methods was evaluated with use of the Bland-Altman 95% limits of agreement, concordance correlation coefficient (CCC), and intraclass correlation coefficient (ICC). Receiver operating characteristic curve analyses were performed to investigate the ability of nHgb monitoring to predict an iHgb of <11.2 g/dL (the 5th-percentile iHgb value). Results: The mean preoperative iHgb was 14.2 ± 1.1 g/dL. The mean postoperative iHgb and nHgb values were 13.3 ± 1.5 and 13.3 ± 1.2 g/dL, respectively. The Bland-Altman 95% limits of agreement were −3.2 and +3.1 g/dL, indicating that 95% of patients’ iHgb values are expected to fall between these limits relative to the nHgb value of the patient. The CCC and ICC were both 0.33. An nHgb cutoff value of <12.7 g/dL had 100% sensitivity and 67% specificity for detecting an iHgb of <11.2 g/dL. Patients reported less pain with the nHgb test than with the iHgb test (mean pain score, 0.0 versus 1.8; p < 0.001), and 97% of patients preferred the nHgb test. Following the nHgb test, 73% of responding patients and 83% of responding nurses were “somewhat more reassured” to “significantly more reassured” about same-day discharge. Conclusions: Routine nHgb testing can rapidly screen patients undergoing outpatient TJA for acute anemia prior to discharge. With an nHgb of <12.7 g/dL, there was perfect sensitivity and 67% specificity for detecting an iHgb of <11.2 g/dL. Most patients and nurses felt more reassured about same-day discharge after nHgb monitoring. Level of Evidence: Diagnostic Level II . See Instructions for Authors for a complete description of levels of evidence.